

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 5.36241273 |
| 2 | response to peptidoglycan (GO:0032494) | 4.80299599 |
| 3 | cellular extravasation (GO:0045123) | 4.34139320 |
| 4 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.30450466 |
| 5 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.20761035 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.10251068 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.10251068 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.10251068 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.10251068 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.10251068 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.10251068 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.73395363 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.70909326 |
| 14 | positive regulation of heat generation (GO:0031652) | 3.67033367 |
| 15 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.61489769 |
| 16 | germinal center formation (GO:0002467) | 3.57573670 |
| 17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57370214 |
| 18 | response to muramyl dipeptide (GO:0032495) | 3.51815312 |
| 19 | detection of external biotic stimulus (GO:0098581) | 3.51637001 |
| 20 | detection of biotic stimulus (GO:0009595) | 3.51560610 |
| 21 | regulation of fever generation (GO:0031620) | 3.22698027 |
| 22 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.13812888 |
| 23 | macrophage activation (GO:0042116) | 3.08139567 |
| 24 | neutrophil mediated immunity (GO:0002446) | 3.05990336 |
| 25 | detection of other organism (GO:0098543) | 3.05470974 |
| 26 | positive regulation of acute inflammatory response (GO:0002675) | 3.01934242 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01598959 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01116539 |
| 29 | embryonic process involved in female pregnancy (GO:0060136) | 3.00718028 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98363738 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96075119 |
| 32 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.95930630 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90186043 |
| 34 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.89256066 |
| 35 | T-helper 1 type immune response (GO:0042088) | 2.89233571 |
| 36 | regulation of vitamin metabolic process (GO:0030656) | 2.81493137 |
| 37 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.80710649 |
| 38 | response to laminar fluid shear stress (GO:0034616) | 2.76563294 |
| 39 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.75049784 |
| 40 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.74675043 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 2.74364566 |
| 42 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74316550 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 2.67839613 |
| 44 | negative regulation of cell killing (GO:0031342) | 2.67651150 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.67651150 |
| 46 | response to host immune response (GO:0052572) | 2.65740350 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65740350 |
| 48 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.65728064 |
| 49 | response to manganese ion (GO:0010042) | 2.64124991 |
| 50 | neutrophil chemotaxis (GO:0030593) | 2.63604971 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.59639823 |
| 52 | response to host (GO:0075136) | 2.59639823 |
| 53 | response to host defenses (GO:0052200) | 2.59639823 |
| 54 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.59149965 |
| 55 | negative regulation of lipid catabolic process (GO:0050995) | 2.56213969 |
| 56 | leukocyte aggregation (GO:0070486) | 2.55482400 |
| 57 | neutrophil migration (GO:1990266) | 2.55377425 |
| 58 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.55040343 |
| 59 | granulocyte activation (GO:0036230) | 2.54965159 |
| 60 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.54296645 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53571376 |
| 62 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.52016213 |
| 63 | tolerance induction (GO:0002507) | 2.51031084 |
| 64 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49265032 |
| 65 | neutrophil activation (GO:0042119) | 2.49091412 |
| 66 | regulation of macrophage cytokine production (GO:0010935) | 2.46935868 |
| 67 | regulation of heat generation (GO:0031650) | 2.46747303 |
| 68 | negative regulation of interleukin-6 production (GO:0032715) | 2.45964136 |
| 69 | decidualization (GO:0046697) | 2.45502210 |
| 70 | regulation of ARF GTPase activity (GO:0032312) | 2.45107820 |
| 71 | histone demethylation (GO:0016577) | 2.44329555 |
| 72 | mRNA transcription (GO:0009299) | 2.43961980 |
| 73 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.43371088 |
| 74 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.43155376 |
| 75 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.42212632 |
| 76 | detection of bacterium (GO:0016045) | 2.41536971 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.41252335 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.40777177 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.38919206 |
| 80 | regulation of type 2 immune response (GO:0002828) | 2.38251718 |
| 81 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.37993372 |
| 82 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.37816554 |
| 83 | negative regulation of interleukin-8 production (GO:0032717) | 2.37263511 |
| 84 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.37039222 |
| 85 | histone lysine demethylation (GO:0070076) | 2.36193432 |
| 86 | ovulation (GO:0030728) | 2.35853725 |
| 87 | histone H3-K36 demethylation (GO:0070544) | 2.35091522 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34875152 |
| 89 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34730687 |
| 90 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.33726666 |
| 91 | cellular response to arsenic-containing substance (GO:0071243) | 2.33658207 |
| 92 | negative regulation of interleukin-1 production (GO:0032692) | 2.32919148 |
| 93 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.31821884 |
| 94 | cellular response to epinephrine stimulus (GO:0071872) | 2.31202428 |
| 95 | regulation of chemokine biosynthetic process (GO:0045073) | 2.29960806 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 2.28989562 |
| 97 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.26320902 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.25233083 |
| 99 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.24560025 |
| 100 | defense response to protozoan (GO:0042832) | 2.23871907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.01095254 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.79604297 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78507510 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43294971 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.39198866 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21932897 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18758862 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.16117207 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15815202 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.14177224 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12144040 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10142871 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05388131 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04889135 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00604490 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.99298137 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99017667 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97722035 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.96098892 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95766614 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95177339 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90778045 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89331075 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85592577 |
| 25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80570585 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72889501 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.72595726 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71851747 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71603990 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.71311808 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.66863706 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62512837 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57307621 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56241543 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56000099 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54876413 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52161224 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51088228 |
| 39 | * MAF_26560356_Chip-Seq_TH1_Human | 1.49384337 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49205288 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46954240 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45908235 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45373106 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45257347 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42178253 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40434778 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37937123 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36289003 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.35488015 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34823740 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32279382 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29902869 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29351621 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28277866 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27708558 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26945355 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26598885 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25402265 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25245882 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24133440 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23118956 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.21409652 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20495246 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17807043 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17639348 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17521133 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17504173 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15863881 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15490685 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15203228 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15159509 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14964160 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14923936 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14875847 |
| 75 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14788433 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13893415 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12781649 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09472261 |
| 79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08739073 |
| 80 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08739073 |
| 81 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08739073 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08725222 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07833114 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07497674 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06750983 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05757087 |
| 87 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05747522 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05153986 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04073369 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04056807 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03892347 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03472597 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02579544 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99322003 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98739577 |
| 96 | * P68_20966046_ChIP-Seq_HELA_Human | 0.98547439 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97786576 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96313456 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95822999 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95713336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.19650342 |
| 2 | MP0003724_increased_susceptibility_to | 3.83545474 |
| 3 | MP0008004_abnormal_stomach_pH | 3.83083044 |
| 4 | MP0003436_decreased_susceptibility_to | 3.56665210 |
| 5 | MP0009278_abnormal_bone_marrow | 3.10878104 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.98193848 |
| 7 | MP0009840_abnormal_foam_cell | 2.83444283 |
| 8 | MP0008260_abnormal_autophagy | 2.48967529 |
| 9 | MP0004510_myositis | 2.26268151 |
| 10 | MP0002254_reproductive_system_inflammat | 2.24568886 |
| 11 | MP0004947_skin_inflammation | 2.24480420 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.14025305 |
| 13 | MP0002419_abnormal_innate_immunity | 2.12615598 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.11411851 |
| 15 | MP0005451_abnormal_body_composition | 2.10893323 |
| 16 | MP0003075_altered_response_to | 2.04691044 |
| 17 | MP0001533_abnormal_skeleton_physiology | 1.95033595 |
| 18 | MP0005076_abnormal_cell_differentiation | 1.91664402 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 1.89518329 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.78791146 |
| 21 | MP0009764_decreased_sensitivity_to | 1.73678323 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.71701192 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.71100433 |
| 24 | MP0003828_pulmonary_edema | 1.70383591 |
| 25 | MP0002998_abnormal_bone_remodeling | 1.63030061 |
| 26 | MP0005025_abnormal_response_to | 1.61798682 |
| 27 | MP0005166_decreased_susceptibility_to | 1.60657656 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.60215738 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.59178849 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.59178849 |
| 31 | MP0009785_altered_susceptibility_to | 1.57493514 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.56404311 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.52960641 |
| 34 | MP0003091_abnormal_cell_migration | 1.52162640 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.50275233 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.45396692 |
| 37 | MP0000685_abnormal_immune_system | 1.43472046 |
| 38 | MP0006082_CNS_inflammation | 1.42995348 |
| 39 | MP0002723_abnormal_immune_serum | 1.41597105 |
| 40 | MP0002132_abnormal_respiratory_system | 1.40142548 |
| 41 | MP0001853_heart_inflammation | 1.37725264 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.36838299 |
| 43 | MP0002405_respiratory_system_inflammati | 1.35016119 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.34051220 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.33975397 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.33609760 |
| 47 | MP0005164_abnormal_response_to | 1.31102816 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.28289968 |
| 49 | MP0001800_abnormal_humoral_immune | 1.28039300 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.26505246 |
| 51 | MP0001790_abnormal_immune_system | 1.26391218 |
| 52 | MP0005387_immune_system_phenotype | 1.26391218 |
| 53 | MP0002006_tumorigenesis | 1.24862614 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.21924652 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.20982335 |
| 56 | MP0004233_abnormal_muscle_weight | 1.20838923 |
| 57 | MP0000858_altered_metastatic_potential | 1.18275384 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.17968186 |
| 59 | MP0005023_abnormal_wound_healing | 1.17618066 |
| 60 | MP0001851_eye_inflammation | 1.17102380 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.16996226 |
| 62 | MP0001819_abnormal_immune_cell | 1.16993637 |
| 63 | MP0005390_skeleton_phenotype | 1.11849149 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.10778730 |
| 65 | MP0008469_abnormal_protein_level | 1.07529991 |
| 66 | MP0003045_fibrosis | 1.04868726 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.00309271 |
| 68 | MP0003448_altered_tumor_morphology | 0.99605429 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.99199880 |
| 70 | MP0000604_amyloidosis | 0.98884178 |
| 71 | MP0005310_abnormal_salivary_gland | 0.97071428 |
| 72 | MP0005409_darkened_coat_color | 0.96768123 |
| 73 | MP0005410_abnormal_fertilization | 0.95700687 |
| 74 | MP0001849_ear_inflammation | 0.94311375 |
| 75 | MP0005275_abnormal_skin_tensile | 0.92999316 |
| 76 | MP0002060_abnormal_skin_morphology | 0.92048066 |
| 77 | MP0003279_aneurysm | 0.91151790 |
| 78 | MP0000249_abnormal_blood_vessel | 0.90839011 |
| 79 | MP0002009_preneoplasia | 0.83668710 |
| 80 | MP0004883_abnormal_blood_vessel | 0.83031562 |
| 81 | MP0002796_impaired_skin_barrier | 0.82764844 |
| 82 | MP0008874_decreased_physiological_sensi | 0.82607536 |
| 83 | MP0000343_altered_response_to | 0.81210129 |
| 84 | MP0003690_abnormal_glial_cell | 0.80442977 |
| 85 | MP0004858_abnormal_nervous_system | 0.80425282 |
| 86 | MP0000716_abnormal_immune_system | 0.80358365 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.79962883 |
| 88 | MP0001958_emphysema | 0.79345959 |
| 89 | MP0005671_abnormal_response_to | 0.78401753 |
| 90 | MP0003329_amyloid_beta_deposits | 0.77771546 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.75514280 |
| 92 | MP0005535_abnormal_body_temperature | 0.75231875 |
| 93 | MP0002933_joint_inflammation | 0.75172595 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.74187776 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.74160191 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.73825839 |
| 97 | MP0002398_abnormal_bone_marrow | 0.73609323 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.72148059 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.71959397 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.71891116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 3.92045871 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 3.67733221 |
| 3 | Optic neuritis (HP:0100653) | 3.67733221 |
| 4 | Myositis (HP:0100614) | 3.55581161 |
| 5 | Amyloidosis (HP:0011034) | 3.39823268 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36754213 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.27891006 |
| 8 | Stomatitis (HP:0010280) | 3.25619866 |
| 9 | Thin bony cortex (HP:0002753) | 3.14976521 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.08238534 |
| 11 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.06030339 |
| 12 | Peritonitis (HP:0002586) | 2.92127732 |
| 13 | Obstructive sleep apnea (HP:0002870) | 2.89360179 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 2.82262901 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 2.71863964 |
| 16 | Deep venous thrombosis (HP:0002625) | 2.61076534 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 2.59271526 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 2.54500778 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 2.44109864 |
| 20 | Keratoconjunctivitis (HP:0001096) | 2.42915472 |
| 21 | Episodic fever (HP:0001954) | 2.42820696 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38789446 |
| 23 | Abnormality of the peritoneum (HP:0002585) | 2.37661879 |
| 24 | Gangrene (HP:0100758) | 2.37321405 |
| 25 | Recurrent abscess formation (HP:0002722) | 2.36659930 |
| 26 | Gingivitis (HP:0000230) | 2.32525375 |
| 27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24194519 |
| 28 | Increased IgE level (HP:0003212) | 2.19284745 |
| 29 | Peripheral hypomyelination (HP:0007182) | 2.14895013 |
| 30 | Vasculitis (HP:0002633) | 2.14304380 |
| 31 | Arterial thrombosis (HP:0004420) | 2.10411945 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.08309136 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07503518 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07503518 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07503518 |
| 36 | Hemorrhage of the eye (HP:0011885) | 2.07047093 |
| 37 | Broad face (HP:0000283) | 2.06949305 |
| 38 | Genu recurvatum (HP:0002816) | 2.06147113 |
| 39 | Pulmonary embolism (HP:0002204) | 2.06111428 |
| 40 | Hemoptysis (HP:0002105) | 2.05543702 |
| 41 | Spondylolisthesis (HP:0003302) | 2.04504449 |
| 42 | Dilatation of the ascending aorta (HP:0005111) | 2.04412449 |
| 43 | Myocardial infarction (HP:0001658) | 2.03438157 |
| 44 | Cerebral aneurysm (HP:0004944) | 2.02270252 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.02034267 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02034267 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.00930445 |
| 48 | Pulmonary infiltrates (HP:0002113) | 1.98267695 |
| 49 | Slow saccadic eye movements (HP:0000514) | 1.97392302 |
| 50 | Protrusio acetabuli (HP:0003179) | 1.95699873 |
| 51 | Increased CSF protein (HP:0002922) | 1.90938137 |
| 52 | Gingival bleeding (HP:0000225) | 1.90717345 |
| 53 | Onion bulb formation (HP:0003383) | 1.87945086 |
| 54 | Glomerulopathy (HP:0100820) | 1.86505504 |
| 55 | Urticaria (HP:0001025) | 1.85959036 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 1.85829895 |
| 57 | Increased connective tissue (HP:0009025) | 1.82119043 |
| 58 | Cervical subluxation (HP:0003308) | 1.81366084 |
| 59 | Ulnar bowing (HP:0003031) | 1.81124507 |
| 60 | Abnormality of the fingertips (HP:0001211) | 1.80612193 |
| 61 | Acne (HP:0001061) | 1.80600638 |
| 62 | Malnutrition (HP:0004395) | 1.80538086 |
| 63 | Spontaneous hematomas (HP:0007420) | 1.80453876 |
| 64 | Aneurysm (HP:0002617) | 1.80331515 |
| 65 | Recurrent skin infections (HP:0001581) | 1.79432291 |
| 66 | Decreased motor nerve conduction velocity (HP:0003431) | 1.77232870 |
| 67 | Anorexia (HP:0002039) | 1.76241282 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 1.75870529 |
| 69 | Dysostosis multiplex (HP:0000943) | 1.74497253 |
| 70 | Abnormality of complement system (HP:0005339) | 1.73527404 |
| 71 | Thick nail (HP:0001805) | 1.73290178 |
| 72 | Spinal cord lesions (HP:0100561) | 1.73242500 |
| 73 | Syringomyelia (HP:0003396) | 1.73242500 |
| 74 | Polygenic inheritance (HP:0010982) | 1.71964385 |
| 75 | Anomalous pulmonary venous return (HP:0010772) | 1.70835029 |
| 76 | Cellulitis (HP:0100658) | 1.69039358 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 1.68201825 |
| 78 | Loss of speech (HP:0002371) | 1.66950211 |
| 79 | Emphysema (HP:0002097) | 1.66572620 |
| 80 | Persistence of primary teeth (HP:0006335) | 1.66482336 |
| 81 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66386588 |
| 82 | Supranuclear gaze palsy (HP:0000605) | 1.66343644 |
| 83 | Vertebral compression fractures (HP:0002953) | 1.66078732 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 1.65650273 |
| 85 | Aortic aneurysm (HP:0004942) | 1.65485152 |
| 86 | Progressive sensorineural hearing impairment (HP:0000408) | 1.64339099 |
| 87 | Blue sclerae (HP:0000592) | 1.63893071 |
| 88 | Germ cell neoplasia (HP:0100728) | 1.63873590 |
| 89 | Axonal loss (HP:0003447) | 1.63577610 |
| 90 | Mitral valve prolapse (HP:0001634) | 1.63294620 |
| 91 | Shallow orbits (HP:0000586) | 1.62602639 |
| 92 | Increased serum ferritin (HP:0003281) | 1.62007605 |
| 93 | Abnormality of the columella (HP:0009929) | 1.61231600 |
| 94 | Mitral stenosis (HP:0001718) | 1.61098151 |
| 95 | Abnormality of the costochondral junction (HP:0000919) | 1.60830254 |
| 96 | Colitis (HP:0002583) | 1.60632762 |
| 97 | Epistaxis (HP:0000421) | 1.60388197 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 1.60233638 |
| 99 | Esophageal varix (HP:0002040) | 1.60144459 |
| 100 | Hypertriglyceridemia (HP:0002155) | 1.59700059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.39451664 |
| 2 | IRAK3 | 3.18365855 |
| 3 | ERN1 | 2.92701059 |
| 4 | RIPK4 | 2.38671070 |
| 5 | MAP3K3 | 2.17241781 |
| 6 | MAP2K3 | 2.00011866 |
| 7 | TAOK2 | 1.96003485 |
| 8 | TAOK1 | 1.94826061 |
| 9 | IRAK2 | 1.94030322 |
| 10 | MAP3K14 | 1.92596637 |
| 11 | TRIB3 | 1.90650943 |
| 12 | SIK1 | 1.89730952 |
| 13 | CDK12 | 1.89112865 |
| 14 | IRAK4 | 1.86729758 |
| 15 | KSR2 | 1.85696519 |
| 16 | MAP4K1 | 1.81637895 |
| 17 | MAP3K1 | 1.76599645 |
| 18 | BLK | 1.72176205 |
| 19 | MAP3K13 | 1.66347043 |
| 20 | ZAP70 | 1.65186191 |
| 21 | IRAK1 | 1.54727367 |
| 22 | RIPK1 | 1.52986882 |
| 23 | MARK2 | 1.52014320 |
| 24 | PIK3CG | 1.42914879 |
| 25 | LATS2 | 1.42420148 |
| 26 | EPHB1 | 1.42195036 |
| 27 | MAP3K11 | 1.41648629 |
| 28 | MAP3K2 | 1.40600906 |
| 29 | TBK1 | 1.39591729 |
| 30 | ARAF | 1.38014033 |
| 31 | IKBKE | 1.34287054 |
| 32 | SMG1 | 1.31101838 |
| 33 | MAP3K9 | 1.29167984 |
| 34 | BMPR2 | 1.28836356 |
| 35 | FGFR4 | 1.26223551 |
| 36 | DDR2 | 1.25023006 |
| 37 | WNK1 | 1.15045773 |
| 38 | PRKD2 | 1.14405222 |
| 39 | TYK2 | 1.14110997 |
| 40 | IKBKB | 1.12658667 |
| 41 | CSK | 1.12058283 |
| 42 | ICK | 1.10431807 |
| 43 | TXK | 1.04649820 |
| 44 | CHUK | 1.03876501 |
| 45 | SIK3 | 1.01793922 |
| 46 | JAK3 | 1.01247390 |
| 47 | CDC42BPA | 0.99060203 |
| 48 | PDPK1 | 0.98546029 |
| 49 | RPS6KA2 | 0.95569543 |
| 50 | JAK1 | 0.93732653 |
| 51 | MAP3K6 | 0.91704536 |
| 52 | STK38 | 0.89730494 |
| 53 | JAK2 | 0.84570549 |
| 54 | PDK1 | 0.84175450 |
| 55 | MAPK7 | 0.83681932 |
| 56 | RPS6KL1 | 0.83292333 |
| 57 | RPS6KC1 | 0.83292333 |
| 58 | TTN | 0.77746991 |
| 59 | GRK6 | 0.74271255 |
| 60 | MAPK15 | 0.72294184 |
| 61 | HIPK2 | 0.70753581 |
| 62 | MATK | 0.70234263 |
| 63 | NLK | 0.70177838 |
| 64 | MTOR | 0.69846899 |
| 65 | HCK | 0.69835625 |
| 66 | INSRR | 0.69680054 |
| 67 | MAPK12 | 0.68718489 |
| 68 | TNK2 | 0.68623561 |
| 69 | MAP2K2 | 0.68557044 |
| 70 | FES | 0.67309979 |
| 71 | EEF2K | 0.66885272 |
| 72 | FGFR3 | 0.66839727 |
| 73 | CAMK1D | 0.66702570 |
| 74 | PDGFRA | 0.66397322 |
| 75 | RAF1 | 0.64178239 |
| 76 | RPS6KA6 | 0.63734960 |
| 77 | FGR | 0.62283744 |
| 78 | SGK3 | 0.62143910 |
| 79 | MAP3K7 | 0.61939448 |
| 80 | PRKD3 | 0.61591379 |
| 81 | TESK2 | 0.61216728 |
| 82 | DYRK1B | 0.57838962 |
| 83 | DAPK2 | 0.56166810 |
| 84 | CAMKK1 | 0.52474094 |
| 85 | BRD4 | 0.51839798 |
| 86 | SGK494 | 0.51343562 |
| 87 | SGK223 | 0.51343562 |
| 88 | PRKG2 | 0.50836175 |
| 89 | MOS | 0.50447647 |
| 90 | RPS6KA1 | 0.50395943 |
| 91 | PDK2 | 0.50138367 |
| 92 | PRKAA2 | 0.50118961 |
| 93 | PDGFRB | 0.48212234 |
| 94 | PAK6 | 0.47872587 |
| 95 | CAMK4 | 0.47601173 |
| 96 | EPHA3 | 0.47304967 |
| 97 | MAP3K5 | 0.46640498 |
| 98 | STK11 | 0.44811481 |
| 99 | NEK6 | 0.44594838 |
| 100 | SIK2 | 0.41587166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.40639689 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30873838 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13822532 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01342262 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97868298 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89925247 |
| 7 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84703525 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 1.76839650 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69922648 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68412457 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60686913 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.60348515 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.60340365 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58766710 |
| 15 | Prion diseases_Homo sapiens_hsa05020 | 1.54028648 |
| 16 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.52948907 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.51586182 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48483839 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42660754 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.40947070 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39633377 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.36038115 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31670775 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27796848 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23081050 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22818755 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20892786 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19617328 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.18886630 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16267580 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15950923 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.15480584 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12456961 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.08764122 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07548219 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06914988 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.06560770 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04563899 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04090393 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03938397 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03886412 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03566233 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02668229 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00145784 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98623512 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98478550 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97740471 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95736576 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90819012 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.90364665 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90099209 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89345718 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88541435 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88474157 |
| 55 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85712522 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.84893738 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84134551 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81686473 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80242649 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80048346 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79326815 |
| 62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79195042 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79175529 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78816816 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.77806671 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77547084 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77477827 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75781995 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.75475102 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71980853 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71902362 |
| 72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70864136 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70802830 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.70281795 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69786339 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69730534 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.67544932 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67159246 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67049002 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67021010 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66463260 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66231954 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64467143 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.64378688 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61522113 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60703684 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.59831395 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58074687 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.57739071 |
| 90 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57716079 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57496063 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51798358 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50738566 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.50566855 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50514884 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47670179 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47387933 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46713250 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.46529204 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.46159159 |

